(Reuters) -Nvidia invested $50 million to speed up training of biotech firm Recursion's artificial intelligence models for drug discovery, which the chip designer can then potentially license out, the companies said on Wednesday.
Recursion shares jumped about 167% in premarket trading on the news.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
